# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-130458
Filing Date
2023-05-01
Accepted
2023-05-01 16:15:52
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d475289dars.pdf | ARS | 1392106
| Complete submission text file | 0001193125-23-130458.txt |  | 1906256

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35890 | Film No.: 23873871
SIC: 2834 Pharmaceutical Preparations